New Drug Doubles One-Year Survival in Pancreatic Cancer Trial
kwm107
Patients who received an experimental drug developed at Northwestern University alongside standard chemotherapy were twice as likely to be alive after one year of treatment, compared to those receiving chemotherapy alone. The post New Drug Doubles One-Year Survival in Pancreatic Cancer Trial appeared first on News Center .